CHEMOPREVENTION OF LUNG CANCER IN THE HIGH INCIDENCE AREA

Since 1984, mass screening for cancer and chemopreventive trials in the two high incidence areas of lung cancer have been carried out. Chemo preventive trials on the subjects having moderate or severe atypical hyperplasia cells in the sputum were done by treatment with R1 [N-(p-ethoxycarbophenyl) re...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:中国癌症研究:英文版 1989 (4), p.53-57
1. Verfasser: 王肇炎 张亚利 肖斌生 胡荣桂 吴开春 张海清 施子廷 蔡杰 韩锐 杨红军 何士林
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 57
container_issue 4
container_start_page 53
container_title 中国癌症研究:英文版
container_volume
creator 王肇炎 张亚利 肖斌生 胡荣桂 吴开春 张海清 施子廷 蔡杰 韩锐 杨红军 何士林
description Since 1984, mass screening for cancer and chemopreventive trials in the two high incidence areas of lung cancer have been carried out. Chemo preventive trials on the subjects having moderate or severe atypical hyperplasia cells in the sputum were done by treatment with R1 [N-(p-ethoxycarbophenyl) retinamide] and R2 [N-(p-carboxyphenyl) retina-mide]. Results showed that the general status of the patients had improved. IgA and IgM in the serum were increased and the arsenic skin lesions were relieved after the treatment with Rl and R2. The ratio of the incidence of lung cancer for the treated group and the control group was 1:4, and the mean degree of hyperplasia in the sputum had dropped. It is suggested that these drugs are both safe and effective in the chemoprevention of lung cancer.
format Article
fullrecord <record><control><sourceid>chongqing</sourceid><recordid>TN_cdi_chongqing_primary_3001441314</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><cqvip_id>3001441314</cqvip_id><sourcerecordid>3001441314</sourcerecordid><originalsourceid>FETCH-chongqing_primary_30014413143</originalsourceid><addsrcrecordid>eNqNiksKwjAUAIMoWD93eOC68ELSSpYlvjYBTaRUt6WI1opWbVfe3i48gKsZhhmxgCslQowFHw-OiKGKUU7ZrO9viNE6Qh4wpQ3t_D6nI7nCegc-he3BZaATpykH66AwBMZmZnBtNzRkSHJKFmxyqe79efnjnK1SKrQJT9dnW7-bti5fXfOouk8pELmUXHAp_ru-ZSow4A</addsrcrecordid><sourcetype>Publisher</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>CHEMOPREVENTION OF LUNG CANCER IN THE HIGH INCIDENCE AREA</title><source>SpringerNature Journals</source><creator>王肇炎 张亚利 肖斌生 胡荣桂 吴开春 张海清 施子廷 蔡杰 韩锐 杨红军 何士林</creator><creatorcontrib>王肇炎 张亚利 肖斌生 胡荣桂 吴开春 张海清 施子廷 蔡杰 韩锐 杨红军 何士林</creatorcontrib><description>Since 1984, mass screening for cancer and chemopreventive trials in the two high incidence areas of lung cancer have been carried out. Chemo preventive trials on the subjects having moderate or severe atypical hyperplasia cells in the sputum were done by treatment with R1 [N-(p-ethoxycarbophenyl) retinamide] and R2 [N-(p-carboxyphenyl) retina-mide]. Results showed that the general status of the patients had improved. IgA and IgM in the serum were increased and the arsenic skin lesions were relieved after the treatment with Rl and R2. The ratio of the incidence of lung cancer for the treated group and the control group was 1:4, and the mean degree of hyperplasia in the sputum had dropped. It is suggested that these drugs are both safe and effective in the chemoprevention of lung cancer.</description><identifier>ISSN: 1000-9604</identifier><identifier>EISSN: 1993-0631</identifier><language>eng</language><subject>atypical ; dropped ; dysplasia ; Hunan ; incidence ; moderate ; retina ; screening ; squamous ; vitamin</subject><ispartof>中国癌症研究:英文版, 1989 (4), p.53-57</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Uhttp://image.cqvip.com/vip1000/qk/85190X/85190X.jpg</thumbnail><link.rule.ids>315,781,785,4025</link.rule.ids></links><search><creatorcontrib>王肇炎 张亚利 肖斌生 胡荣桂 吴开春 张海清 施子廷 蔡杰 韩锐 杨红军 何士林</creatorcontrib><title>CHEMOPREVENTION OF LUNG CANCER IN THE HIGH INCIDENCE AREA</title><title>中国癌症研究:英文版</title><addtitle>Chinese Journal of Cancer Research</addtitle><description>Since 1984, mass screening for cancer and chemopreventive trials in the two high incidence areas of lung cancer have been carried out. Chemo preventive trials on the subjects having moderate or severe atypical hyperplasia cells in the sputum were done by treatment with R1 [N-(p-ethoxycarbophenyl) retinamide] and R2 [N-(p-carboxyphenyl) retina-mide]. Results showed that the general status of the patients had improved. IgA and IgM in the serum were increased and the arsenic skin lesions were relieved after the treatment with Rl and R2. The ratio of the incidence of lung cancer for the treated group and the control group was 1:4, and the mean degree of hyperplasia in the sputum had dropped. It is suggested that these drugs are both safe and effective in the chemoprevention of lung cancer.</description><subject>atypical</subject><subject>dropped</subject><subject>dysplasia</subject><subject>Hunan</subject><subject>incidence</subject><subject>moderate</subject><subject>retina</subject><subject>screening</subject><subject>squamous</subject><subject>vitamin</subject><issn>1000-9604</issn><issn>1993-0631</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1989</creationdate><recordtype>article</recordtype><recordid>eNqNiksKwjAUAIMoWD93eOC68ELSSpYlvjYBTaRUt6WI1opWbVfe3i48gKsZhhmxgCslQowFHw-OiKGKUU7ZrO9viNE6Qh4wpQ3t_D6nI7nCegc-he3BZaATpykH66AwBMZmZnBtNzRkSHJKFmxyqe79efnjnK1SKrQJT9dnW7-bti5fXfOouk8pELmUXHAp_ru-ZSow4A</recordid><startdate>1989</startdate><enddate>1989</enddate><creator>王肇炎 张亚利 肖斌生 胡荣桂 吴开春 张海清 施子廷 蔡杰 韩锐 杨红军 何士林</creator><scope>2RA</scope><scope>92L</scope><scope>CQIGP</scope><scope>W91</scope><scope>~WA</scope></search><sort><creationdate>1989</creationdate><title>CHEMOPREVENTION OF LUNG CANCER IN THE HIGH INCIDENCE AREA</title><author>王肇炎 张亚利 肖斌生 胡荣桂 吴开春 张海清 施子廷 蔡杰 韩锐 杨红军 何士林</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-chongqing_primary_30014413143</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1989</creationdate><topic>atypical</topic><topic>dropped</topic><topic>dysplasia</topic><topic>Hunan</topic><topic>incidence</topic><topic>moderate</topic><topic>retina</topic><topic>screening</topic><topic>squamous</topic><topic>vitamin</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>王肇炎 张亚利 肖斌生 胡荣桂 吴开春 张海清 施子廷 蔡杰 韩锐 杨红军 何士林</creatorcontrib><collection>维普_期刊</collection><collection>中文科技期刊数据库-CALIS站点</collection><collection>维普中文期刊数据库</collection><collection>维普中文医药期刊数据库</collection><collection>中文科技期刊数据库- 镜像站点</collection><jtitle>中国癌症研究:英文版</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>王肇炎 张亚利 肖斌生 胡荣桂 吴开春 张海清 施子廷 蔡杰 韩锐 杨红军 何士林</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>CHEMOPREVENTION OF LUNG CANCER IN THE HIGH INCIDENCE AREA</atitle><jtitle>中国癌症研究:英文版</jtitle><addtitle>Chinese Journal of Cancer Research</addtitle><date>1989</date><risdate>1989</risdate><issue>4</issue><spage>53</spage><epage>57</epage><pages>53-57</pages><issn>1000-9604</issn><eissn>1993-0631</eissn><abstract>Since 1984, mass screening for cancer and chemopreventive trials in the two high incidence areas of lung cancer have been carried out. Chemo preventive trials on the subjects having moderate or severe atypical hyperplasia cells in the sputum were done by treatment with R1 [N-(p-ethoxycarbophenyl) retinamide] and R2 [N-(p-carboxyphenyl) retina-mide]. Results showed that the general status of the patients had improved. IgA and IgM in the serum were increased and the arsenic skin lesions were relieved after the treatment with Rl and R2. The ratio of the incidence of lung cancer for the treated group and the control group was 1:4, and the mean degree of hyperplasia in the sputum had dropped. It is suggested that these drugs are both safe and effective in the chemoprevention of lung cancer.</abstract></addata></record>
fulltext fulltext
identifier ISSN: 1000-9604
ispartof 中国癌症研究:英文版, 1989 (4), p.53-57
issn 1000-9604
1993-0631
language eng
recordid cdi_chongqing_primary_3001441314
source SpringerNature Journals
subjects atypical
dropped
dysplasia
Hunan
incidence
moderate
retina
screening
squamous
vitamin
title CHEMOPREVENTION OF LUNG CANCER IN THE HIGH INCIDENCE AREA
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-17T17%3A46%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-chongqing&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=CHEMOPREVENTION%20OF%20LUNG%20CANCER%20IN%20THE%20HIGH%20INCIDENCE%20AREA&rft.jtitle=%E4%B8%AD%E5%9B%BD%E7%99%8C%E7%97%87%E7%A0%94%E7%A9%B6%EF%BC%9A%E8%8B%B1%E6%96%87%E7%89%88&rft.au=%E7%8E%8B%E8%82%87%E7%82%8E%20%E5%BC%A0%E4%BA%9A%E5%88%A9%20%E8%82%96%E6%96%8C%E7%94%9F%20%E8%83%A1%E8%8D%A3%E6%A1%82%20%E5%90%B4%E5%BC%80%E6%98%A5%20%E5%BC%A0%E6%B5%B7%E6%B8%85%20%E6%96%BD%E5%AD%90%E5%BB%B7%20%E8%94%A1%E6%9D%B0%20%E9%9F%A9%E9%94%90%20%E6%9D%A8%E7%BA%A2%E5%86%9B%20%E4%BD%95%E5%A3%AB%E6%9E%97&rft.date=1989&rft.issue=4&rft.spage=53&rft.epage=57&rft.pages=53-57&rft.issn=1000-9604&rft.eissn=1993-0631&rft_id=info:doi/&rft_dat=%3Cchongqing%3E3001441314%3C/chongqing%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_cqvip_id=3001441314&rfr_iscdi=true